Zegalogue Autoinjector
Zegalogue Autoinjector Uses, Dosage, Side Effects, Food Interaction and all others data.
Zegalogue Autoinjector is under investigation in clinical trial NCT03735225 (Evaluation of the Safety, Tolerability and Bioavailability of Zegalogue Autoinjector Following Subcutaneous (SC) Compared to IV Administration).
| Trade Name | Zegalogue Autoinjector |
| Availability | Prescription only |
| Generic | Dasiglucagon |
| Dasiglucagon Other Names | Dasiglucagon |
| Related Drugs | glucagon, Baqsimi, diazoxide, Gvoke, GlucaGen, Proglycem |
| Weight | 0.6mg/0.6ml, |
| Type | Subcutaneous solution |
| Groups | Approved, Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | United States |
| Last Updated: | September 19, 2023 at 7:00 am |
Zegalogue Autoinjector Disease Interaction
Major: insulinoma, pheochromocytomaModerate: glycogen depletion
Innovators Monograph
You find simplified version here Zegalogue Autoinjector
